Open AccessOutcomes of Peginterferon Alpha-2a and Ribavirin Hepatitis C therapy in Aboriginal Canadians
Author(s) -
Curtis Cooper,
Robert J. Bailey,
Vincent G. Bain,
Frank Anderson,
Eric M. Yoshida,
Mel Krajden,
Paul Marotta,
for the Canadian Pegasys Study Group
Publication year - 2008
Publication title -
canadian journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1916-7237
pISSN - 0835-7900
DOI - 10.1155/2008/320150
Subject(s) - medicine , ribavirin , hepatitis c , population , hepatitis c virus , cohort , adverse effect , immunology , virus , environmental health
There is little published information on baseline characteristics and therapeutic outcomes in hepatitis C virus (HCV)-infected Aboriginal Canadians. It is unclear what proportion of HCV-infected Aboriginal people receive therapy relative to other populations.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom